VHL and cancer: Based on genome-wide association studies to screen for population-based cancer susceptibility loci, this intergenic remote HRE has been identified as a susceptibility locus for renal cell carcinoma, regulating CCND1 expression via HIF-2 specifically in VHL-defective renal cancer cells.